Virtus LifeSci Biotech Products ETF
12 hedge funds and large institutions have $7.13M invested in Virtus LifeSci Biotech Products ETF in 2021 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$566K | |
| 2 | +$137K | |
| 3 | +$21.5K | |
| 4 |
NFG
Next Financial Group
Houston,
Texas
|
+$2.67K |
| 5 |
Morgan Stanley
New York
|
+$877 |
Top Sellers
| 1 | -$389K | |
| 2 | -$172K | |
| 3 | -$58.6K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$46K |
| 5 |
SMG
Smart Money Group
Eastland,
Texas
|
-$40.4K |